0,792  0,005  Cognition disorders treatment
0,665  0,008  Cardiovascular analeptic
0,589  0,008  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,585  0,007  Calcium channel L-type activator
0,576  0,005  Sigma receptor agonist
0,556  0,013  GABA C receptor rho-3 antagonist
0,551  0,020  Antipsychotic
0,523  0,009  Psychostimulant
0,518  0,020  Analeptic
0,517  0,025  Vasodilator, peripheral
0,511  0,026  CYP2C19 substrate
0,489  0,013  Anticonvulsant
0,484  0,009  Muscle relaxant
0,497  0,028  5 Hydroxytryptamine release stimulant
0,489  0,021  Nootropic
0,489  0,023  FMO1 substrate
0,463  0,007  Antiparkinsonian, rigidity relieving
0,462  0,007  Prostate disorders treatment
0,485  0,031  Respiratory analeptic
0,465  0,013  Interleukin 2 agonist
0,461  0,012  Interleukin agonist
0,473  0,024  Antiepileptic
0,457  0,009  Prostatic (benign) hyperplasia treatment
0,461  0,013  Sedative
0,455  0,008  Male reproductive disfunction treatment
0,446  0,005  Erectile dysfunction treatment
0,476  0,041  CYP2C9 substrate
0,461  0,032  Anxiolytic
0,430  0,005  Antiparkinsonian, tremor relieving
0,434  0,011  FMO3 substrate
0,434  0,024  Antineurogenic pain
0,458  0,049  CYP3A4 substrate
0,405  0,005  5 Hydroxytryptamine 1F antagonist
0,436  0,036  CYP2D6 substrate
0,459  0,062  Analgesic
0,430  0,034  Spasmolytic
0,403  0,016  Flavin-containing monooxygenase substrate
0,431  0,055  Antipruritic, allergic
0,415  0,041  Antineoplastic (non-Hodgkin's lymphoma)
0,379  0,011  Skeletal muscle relaxant
0,450  0,083  Caspase 9 stimulant
0,374  0,007  CNS active muscle relaxant
0,369  0,004  Polo-like kinase-4 inhibitor
0,435  0,076  Alzheimer's disease treatment
0,388  0,029  Calcium channel activator
0,369  0,012  Tyrosine 3 hydroxylase inhibitor
0,414  0,058  Antineoplastic (myeloid leukemia)
0,373  0,020  5 Hydroxytryptamine uptake stimulant
0,380  0,030  Antihypoxic
0,403  0,057  Ulceration
0,392  0,048  Aldehyde oxidase inhibitor
0,342  0,009  Acetylcholine M1 receptor antagonist
0,367  0,036  Radiosensitizer
0,335  0,009  Toxic, respiratory center
0,336  0,013  Alpha-N-acetylglucosaminidase inhibitor
0,341  0,019  Antimigraine
0,364  0,048  CYP1A2 substrate
0,369  0,054  Antidepressant
0,328  0,017  Pneumotoxic
0,327  0,017  Antialcoholic
0,315  0,006  Ferrochelatase inhibitor
0,343  0,034  Potassium channel blocker
0,367  0,061  Mood disorders treatment
0,332  0,027  Anesthetic general
0,305  0,004  Acetylcholine muscarinic agonist
0,315  0,024  Gastrin inhibitor
0,379  0,088  Antiparkinsonian
0,319  0,035  Cyclic AMP phosphodiesterase inhibitor
0,365  0,081  GST A substrate
0,297  0,018  Sepsis treatment
0,283  0,006  Acetylcholine agonist
0,289  0,014  Antidiabetic (type 1)
0,285  0,012  Carcinogenic, group 1
0,291  0,020  Cholinergic
0,300  0,030  5 Hydroxytryptamine 1E antagonist
0,274  0,004  Acetylcholine M1 receptor agonist
0,339  0,070  Bone diseases treatment
0,275  0,011  GABA C receptor agonist
0,265  0,005  5 Hydroxytryptamine 3A agonist
0,345  0,090  Immunosuppressant
0,305  0,051  Cytostatic
0,271  0,018  Cholinergic antagonist
0,256  0,004  Antihypermotility
0,296  0,045  DNA synthesis inhibitor
0,267  0,018  Acetylcholine antagonist
0,313  0,065  CTGF expression inhibitor
0,258  0,013  Acetylcholine muscarinic antagonist
0,255  0,011  Antiemetic
0,245  0,004  Antileprosy
0,296  0,056  Amyotrophic lateral sclerosis treatment
0,255  0,015  Uterine stimulant
0,304  0,065  Antiosteoporotic
0,298  0,062  UGT1A9 substrate
0,273  0,037  DNA methyltransferase I inhibitor
0,315  0,079  Antithrombotic
0,340  0,105  TNF expression inhibitor
0,311  0,078  Vasodilator, coronary
0,259  0,027  Hair growth stimulant
0,248  0,017  5 Hydroxytryptamine 3E antagonist
0,259  0,030  Antianorexic
0,292  0,064  Insulysin inhibitor
0,285  0,059  GST M1-1 substrate
0,266  0,041  RNA-directed DNA polymerase inhibitor
0,265  0,043  Abortion inducer
0,227  0,005  Acetylcholine M4 receptor antagonist
0,228  0,007  Hearing loss treatment
0,221  0,004  Acetylcholine release stimulant
0,222  0,006  Myasthenia Gravis treatment
0,243  0,028  NOS3 expression enhancer
0,280  0,065  Cardiotonic
0,325  0,111  Histamine release inhibitor
0,227  0,016  Antismoking
0,251  0,041  UGT1A4 substrate
0,254  0,046  DNA methylase inhibitor
0,214  0,007  Prolactin inhibitor
0,217  0,011  Antiprotozoal (Babesia)
0,225  0,020  Antiadrenergic
0,237  0,033  Irritable Bowel syndrome treatment
0,230  0,027  Aldehyde oxidase substrate
0,265  0,063  Cardiodepressant
0,291  0,088  Sodium/bile acid cotransporter inhibitor
0,222  0,020  Adrenaline antagonist
0,262  0,062  HERG channel blocker
0,265  0,066  Heart failure treatment
0,203  0,005  Antidote, mercury
0,223  0,026  Anesthetic local
0,199  0,005  Cushing's syndrome treatment
0,273  0,079  Radioprotector
0,215  0,022  GABA C receptor rho-2 antagonist
0,197  0,005  Acetylcholine M3 receptor agonist
0,225  0,035  Attention deficit/hyperactivity disorder treatment
0,210  0,021  Raynaud's phenomenon treatment
0,246  0,058  Antihypotensive
0,261  0,073  Teratogen
0,246  0,060  Dependence treatment
0,190  0,005  Acetylcholine M5 receptor antagonist
0,199  0,014  Antineoplastic, alkylator
0,191  0,007  Acetylcholine M2 receptor antagonist
0,186  0,003  Acetylcholine M5 receptor agonist
0,332  0,149  Autoimmune disorders treatment
0,224  0,043  Lipocortins synthesis antagonist
0,189  0,008  Female sexual dysfunction treatment
0,243  0,062  Transplant rejection treatment
0,234  0,055  Antiviral (West Nile virus)
0,222  0,043  Histone acetyltransferase inhibitor
0,215  0,037  VEGF expression inhibitor
0,247  0,068  Potassium channel (Voltage-sensitive) blocker
0,230  0,052  Sleep disorders treatment
0,182  0,005  Dopamine D5 antagonist
0,300  0,123  Rheumatoid arthritis treatment
0,187  0,011  Hematopoietic
0,215  0,041  Cytidine deaminase inhibitor
0,201  0,027  Neurotrophic factor
0,208  0,035  UGT2B9 substrate
0,183  0,011  Electrolyte absorption antagonist
0,199  0,028  Alpha adrenoreceptor antagonist
0,176  0,006  Narcolepsy treatment
0,197  0,030  Antinephritic
0,221  0,054  Focal adhesion kinase 2 inhibitor
0,241  0,075  Embryotoxic
0,193  0,028  5 Hydroxytryptamine 2B antagonist
0,196  0,031  5 Hydroxytryptamine 2 antagonist
0,200  0,036  Phobic disorders treatment
0,188  0,024  Excitatory amino acid transporter EAAC1 inhibitor
0,209  0,046  Antiviral (Ebola)
0,177  0,013  Glutamate receptor agonist
0,184  0,022  GABA receptor agonist
0,233  0,071  MAP-kinase-activated kinase 5 inhibitor
0,168  0,007  Glutamate (mGluR7) agonist
0,181  0,021  Menstruation disorders treatment
0,188  0,028  Antitussive
0,183  0,024  Endometrios treatment
0,164  0,005  Tourette's syndrome treatment
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,254  0,095  Ca(v)3.3 blocker
0,181  0,024  Alpha 1 adrenoreceptor antagonist
0,266  0,109  Multiple sclerosis treatment
0,202  0,047  Antipruritic
0,208  0,053  Antiviral (Hepatitis)
0,197  0,042  Antirickettsial
0,170  0,016  Acetylcholine nicotinic antagonist
0,245  0,093  UGT2B4 substrate
0,288  0,137  Analgesic, non-opioid
0,221  0,070  Fibrosis treatment
0,209  0,059  P-glycoprotein inhibitor
0,164  0,014  Contraceptive male
0,190  0,041  Neurotensin receptor agonist
0,171  0,022  Antineoplastic alkaloid
0,157  0,009  Dyspepsia treatment
0,179  0,031  Movement disorders treatment
0,169  0,021  GABA C receptor antagonist
0,177  0,030  Autism spectrum disorders treatment
0,193  0,047  Antiviral (Hepatitis C)
0,163  0,017  GABA C receptor rho-1 antagonist
0,240  0,094  Huntington's disease treatment
0,232  0,087  Superoxide dismutase inhibitor
0,190  0,045  UGT2B10 substrate
0,188  0,045  Antiacne
0,145  0,003  Antidote, organophosphates
0,169  0,028  Falcipain 3 inhibitor
0,191  0,051  Restenosis treatment
0,236  0,096  Chemoprotective
0,165  0,025  NAT2 substrate
0,179  0,039  5 Hydroxytryptamine antagonist
0,232  0,093  Ca2+/calmodulin-dependent kinase IV inhibitor
0,177  0,038  Psychosexual dysfunction treatment
0,148  0,010  Phosphodiesterase 6D inhibitor
0,189  0,051  Muscular dystrophy treatment
0,168  0,030  Antiviral (Poxvirus)
0,152  0,016  GST T1-1 substrate
0,161  0,025  5 Hydroxytryptamine 2A antagonist
0,152  0,018  Interleukin 2 antagonist
0,147  0,013  Neuronal nicotinic receptor antagonist
0,146  0,012  Restless leg syndrome treatment
0,176  0,043  Cell wall synthesis inhibitor
0,154  0,024  Chronic obstructive bronchitis treatment
0,195  0,065  Systemic lupus erythematosus treatment
0,151  0,022  Alpha 1b adrenoreceptor antagonist
0,133  0,004  Antihemophilic
0,152  0,023  Creatine kinase inhibitor
0,156  0,028  Protein kinase C gamma inhibitor
0,200  0,072  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,141  0,015  Tocolytic
0,145  0,019  Polo-like kinase-1 inhibitor
0,151  0,025  Sphingosine 1-phosphate receptor 2 agonist
0,151  0,026  Antiinfertility, female
0,142  0,017  Histamine N-methyltransferase inhibitor
0,186  0,061  Succinate dehydrogenase inhibitor
0,174  0,050  Anesthetic
0,132  0,009  Antiviral (Hepatitis A)
0,148  0,026  Dementia treatment
0,207  0,088  UGT1A6 substrate
0,138  0,019  5 Hydroxytryptamine 7 antagonist
0,155  0,036  Heat shock protein 70 antagonist
0,132  0,014  CXC chemokine receptor antagonist
0,179  0,062  Anticoagulant
0,168  0,052  Toll-Like receptor 9 antagonist
0,163  0,046  Cocaine dependence treatment
0,131  0,014  Focal adhesion kinase 1 inhibitor
0,142  0,026  Vascular dementia treatment
0,132  0,016  Bromodomain-containing protein 2 inhibitor
0,174  0,059  Neuropathy treatment
0,184  0,070  LDLR expression enhancer
0,140  0,027  Histamine H1 receptor antagonist
0,117  0,004  Acetylcholine M4 receptor agonist
0,165  0,052  Hemostatic
0,138  0,026  Carcinogenic, group 2A
0,126  0,015  Nicotinic alpha4beta2 receptor antagonist
0,142  0,032  UDP-glucose 4-epimerase inhibitor
0,199  0,090  Nitric-oxide synthase stimulant
0,178  0,069  Tumour necrosis factor antagonist
0,123  0,015  Benzodiazepine agonist
0,170  0,061  Cyclin-dependent kinase 8 inhibitor
0,113  0,004  Antihyperaldosteronism
0,113  0,005  Glutamate (mGluR5) agonist
0,157  0,050  Cachexia treatment
0,169  0,062  Diuretic
0,115  0,008  Protein kinase C beta inhibitor
0,142  0,035  Antiviral (Influenza B)
0,287  0,180  5 Hydroxytryptamine release inhibitor
0,210  0,103  Neuropeptide Y2 antagonist
0,113  0,007  Dipeptidyl peptidase inhibitor
0,131  0,025  Mental retardation treatment
0,119  0,014  Acetylcholine M3 receptor antagonist
0,120  0,015  Caspase 7 inhibitor
0,111  0,006  Glutamate (mGluR7) antagonist
0,111  0,007  Glutamate (mGluR group I) agonist
0,157  0,052  Adenylate cyclase stimulant
0,123  0,019  Phosphodiesterase 11A inhibitor
0,123  0,019  Phosphodiesterase XI inhibitor
0,120  0,017  5 Hydroxytryptamine 1B antagonist
0,114  0,010  5 Hydroxytryptamine 3 agonist
0,263  0,160  CYP2C19 inhibitor
0,225  0,122  Antiischemic
0,130  0,027  Triose-phosphate isomerase inhibitor
0,159  0,057  SULT1A3 substrate
0,165  0,063  Acaricide
0,110  0,009  5-Alpha-reductase inhibitor
0,114  0,013  Sleep apnea treatment
0,116  0,015  Viral attachment inhibitor
0,143  0,044  Cystathionine beta-synthase inhibitor
0,144  0,044  Gastritis treatment
0,103  0,004  5-Alpha-reductase 1 inhibitor
0,109  0,011  Nicotinic receptor alpha7 subunit antagonist
0,103  0,006  Corticotropin releasing factor 2 receptor antagonist
0,128  0,030  Androgen antagonist
0,127  0,030  Dopamine antagonist
0,102  0,005  GHS receptor agonist
0,130  0,034  Vasculitis treatment
0,139  0,043  Contraceptive female
0,144  0,049  Sphingosine 1-phosphate receptor 2 antagonist
0,100  0,005  5-Alpha-reductase 2 inhibitor
0,146  0,051  Antihelmintic (Trematoda)
0,103  0,009  Phosphodiesterase 1A inhibitor
0,143  0,050  Alkylator
0,111  0,018  Carbamoyl phosphate synthetase inhibitor
0,233  0,140  Transcription factor NF kappa B inhibitor
0,114  0,021  Glycine receptor antagonist
0,138  0,045  Alpha 2b adrenoreceptor antagonist
0,112  0,020  Glutamate (mGluR) agonist
0,135  0,043  Constipation treatment
0,113  0,021  Dopamine D1 antagonist
0,148  0,056  Pregnane X receptor agonist
0,156  0,067  Pulmonary hypertension treatment
0,099  0,010  Nicotinic receptor alpha3 subunit antagonist
0,108  0,019  Narcotic antagonist
0,184  0,094  Neurotrophic factor enhancer
0,094  0,005  Dipeptidyl peptidase IV inhibitor
0,163  0,074  Antihelmintic (Nematodes)
0,102  0,013  Phospholipase D inhibitor
0,153  0,065  Activin receptor-like kinase 2 inhibitor
0,160  0,072  Eye irritation, high
0,117  0,030  NADH dehydrogenase inhibitor
0,102  0,015  Vanilloid 4 agonist
0,151  0,064  Antianemic
0,114  0,029  Dopamine D2 antagonist
0,227  0,142  Cholesterol antagonist
0,145  0,060  Nav1.6 sodium channel blocker
0,103  0,018  Phosphodiesterase VI inhibitor
0,100  0,015  5 Hydroxytryptamine 5A antagonist
0,116  0,031  5 Hydroxytryptamine 1 antagonist
0,092  0,008  Prolyl endopeptidase inhibitor
0,117  0,033  Antispirochetal
0,128  0,044  Alpha 2c adrenoreceptor antagonist
0,124  0,041  Antihistaminic
0,101  0,018  Bulimia treatment
0,102  0,019  CC chemokine 5 receptor agonist
0,097  0,015  Orexin receptor 1 antagonist
0,097  0,015  Uterine relaxant
0,113  0,031  Alpha 1a adrenoreceptor antagonist
0,123  0,041  Adenylate kinase inhibitor
0,162  0,080  UGT2B7 substrate
0,112  0,031  Gastroesophageal reflux disease treatment
0,091  0,010  Nicotinic alpha3beta2 receptor antagonist
0,186  0,106  VCAM1 expression inhibitor
0,119  0,039  Ca(v)2.2 blocker
0,112  0,032  Phosphodiesterase I inhibitor
0,218  0,138  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,104  0,025  Phosphodiesterase 5A inhibitor
0,146  0,067  Sphingosine 1-phosphate receptor 5 antagonist
0,099  0,021  Prokinetic
0,150  0,072  Antidote
0,133  0,055  Antiviral (Papilloma)
0,097  0,019  Secretase beta inhibitor
0,104  0,026  Aminopeptidase I inhibitor
0,104  0,026  Sodium/hydrogen exchanger 5 inhibitor
0,135  0,057  TRKB antagonist
0,109  0,031  Acetylcholine nicotinic agonist
0,088  0,010  Acetylcholine M2 receptor agonist
0,142  0,065  Bone formation stimulant
0,213  0,136  CYP2D6 inhibitor
0,100  0,023  Alpha 1d adrenoreceptor antagonist
0,197  0,120  Chronic obstructive pulmonary disease treatment
0,137  0,061  Carcinogenic, group 3
0,116  0,040  Histamine antagonist
0,108  0,032  Glutamate release inhibitor
0,086  0,010  5 Hydroxytryptamine 7 agonist
0,102  0,027  Phosphodiesterase V inhibitor
0,082  0,008  Ryanodine receptor antagonist
0,130  0,055  DNA repair enzyme inhibitor
0,128  0,054  Calcium channel N-type blocker
0,094  0,020  5 Hydroxytryptamine 3A antagonist
0,150  0,076  Antimutagenic
0,090  0,015  Bromodomain-containing protein 4 inhibitor
0,092  0,018  Acyl-CoA dehydrogenase inhibitor
0,092  0,018  Androgen agonist
0,091  0,017  Orexin receptor antagonist
0,117  0,044  Insulin receptor antagonist
0,090  0,017  Antimycoplasmal
0,077  0,005  Vascular adhesion protein 1 inhibitor
0,096  0,023  Glycine receptor agonist
0,079  0,007  Cholesterol esterase inhibitor
0,076  0,005  CXC chemokine 3 receptor antagonist
0,081  0,010  Anesthetic inhalation
0,081  0,010  Prolactin release inhibitor
0,090  0,020  Protease 3C (Human rhinovirus) inhibitor
0,154  0,084  Arachidonic acid antagonist
0,086  0,018  Antiviral (Parainfluenza)
0,086  0,018  5 Hydroxytryptamine 5 antagonist
0,120  0,053  Rhinitis treatment
0,101  0,034  Ankylosing spondylitis treatment
0,144  0,077  Antiischemic, cerebral
0,123  0,056  Shock treatment
0,134  0,067  Antiprotozoal (Trichomonas)
0,190  0,123  Calpain inhibitor
0,096  0,030  Estrogen-related receptor beta agonist
0,093  0,027  Dopamine D3 antagonist
0,098  0,032  Analgesic, opioid
0,110  0,045  UGT2B11 substrate
0,079  0,014  Histamine agonist
0,081  0,016  Peristaltic stimulant
0,077  0,012  Alpha-mannosidase inhibitor
0,094  0,030  Lipase inhibitor
0,096  0,032  Glutamate decarboxylase inhibitor
0,109  0,046  Interleukin 1 beta converting enzyme inhibitor
0,094  0,031  Polo-like kinase-2 inhibitor
0,068  0,006  Nerve growth factor antagonist
0,067  0,005  Kainate receptor agonist
0,096  0,034  5 Hydroxytryptamine 1A antagonist
0,147  0,085  UGT1A3 substrate
0,073  0,012  Antiviral (Hepatitis D)
0,069  0,008  Purinergic P2X7 antagonist
0,097  0,037  mTOR complex 2 inhibitor
0,084  0,024  Biliverdin reductase inhibitor
0,110  0,050  Anabolic
0,107  0,048  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,117  0,058  Nav1.5 sodium channel blocker
0,088  0,028  MAP kinase kinase 7 inhibitor
0,079  0,020  Phosphodiesterase 1C inhibitor
0,086  0,028  MAP kinase 7 inhibitor
0,119  0,061  Transcription factor STAT6 inhibitor
0,136  0,078  Protein kinase stimulant
0,165  0,107  CYP2B6 inhibitor
0,108  0,051  Sphingomyelinase inhibitor
0,102  0,045  Bile acid receptor antagonist
0,077  0,021  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,079  0,023  Phosphodiesterase 1B inhibitor
0,152  0,096  Antipruritic, non-allergic
0,099  0,044  Arylamine N-Acetyltransferase substrate
0,172  0,117  Antineoplastic enhancer
0,161  0,106  UGT1A1 substrate
0,071  0,017  5 Hydroxytryptamine 1B agonist
0,102  0,048  Protein kinase C zeta inhibitor
0,079  0,025  Glutamate (mGluR6) antagonist
0,080  0,026  SULT2A1 substrate
0,184  0,130  Immunostimulant
0,060  0,007  Delayed rectifier potassium channel blocker
0,070  0,016  Neurokinin 2 antagonist
0,072  0,019  Neurokinin antagonist
0,066  0,013  Oxytocin agonist
0,096  0,044  ALK inhibitor
0,069  0,017  Nicotinic receptor alpha4 subunit antagonist
0,082  0,030  Potassium channel (Tandem pore domain) blocker
0,093  0,042  Histamine H2 receptor antagonist
0,077  0,026  5 Hydroxytryptamine 1 agonist
0,189  0,138  Proliferative diseases treatment
0,064  0,014  Mannosidase inhibitor
0,068  0,018  Antidiuretic hormone antagonist
0,073  0,024  Cyclin D1 inhibitor
0,066  0,017  HCV NS3/NS4A protease inhibitor
0,160  0,112  MAP kinase kinase 2 inhibitor
0,128  0,080  Tyrosine-protein kinase receptor antagonist
0,173  0,125  Urologic disorders treatment
0,108  0,060  Aminopeptidase B inhibitor
0,053  0,006  Cyclophilin A inhibitor
0,052  0,004  Protease (Human cytomegalovirus) inhibitor
0,060  0,013  Glutamate (mGluR group III) antagonist
0,097  0,050  Alpha 2 adrenoreceptor antagonist
0,151  0,104  Diabetic nephropathy treatment
0,086  0,040  Glutamate dehydrogenase inhibitor
0,051  0,005  Nicotinic alpha3beta4 receptor agonist
0,126  0,080  Calcium channel blocker
0,051  0,005  Adenosine uptake inhibitor
0,078  0,032  5 Hydroxytryptamine 1D antagonist
0,084  0,039  Phosphofructokinase-1 inhibitor
0,088  0,042  Porphobilinogen synthase inhibitor
0,118  0,073  Antiprotozoal (Amoeba)
0,101  0,055  MAP kinase kinase 1 inhibitor
0,116  0,071  Adenylate cyclase inhibitor
0,088  0,043  Alpha 2a adrenoreceptor antagonist
0,099  0,055  Posttraumatic stress disorder treatment
0,068  0,025  Kallikrein 1 inhibitor
0,119  0,075  Nav1.3 sodium channel blocker
0,056  0,012  Phosphodiesterase 6C inhibitor
0,124  0,080  Sodium channel (voltage-gated) blocker
0,055  0,012  GABA uptake inhibitor
0,069  0,026  Fatty acid synthase inhibitor
0,047  0,005  Nicotinic alpha4beta2 receptor agonist
0,134  0,092  Neuropeptide Y1 antagonist
0,067  0,026  Nicotinic alpha7 receptor agonist
0,069  0,029  Alcohol oxidase inhibitor
0,062  0,022  Potassium channel (Inward rectifier) blocker
0,062  0,022  5 Hydroxytryptamine 4 antagonist
0,069  0,029  Nicotinic neuronal receptor agonist
0,043  0,004  Acid ceramidase inhibitor
0,077  0,039  Dysmenorrhea treatment
0,121  0,082  Nav1.2 sodium channel blocker
0,068  0,029  Alpha 1 adrenoreceptor agonist
0,214  0,176  Calpain 2 inhibitor
0,073  0,036  Exportin-1 inhibitor
0,086  0,049  Opioid kappa receptor antagonist
0,050  0,013  Orexin receptor 2 antagonist
0,146  0,109  ATPase inhibitor
0,083  0,047  Interferon agonist
0,043  0,007  LFA antagonist
0,066  0,030  5 Hydroxytryptamine 3 antagonist
0,056  0,021  Adenylate cyclase 1 inhibitor
0,096  0,061  Lanosterol 14 alpha demethylase inhibitor
0,200  0,165  Immunomodulator
0,068  0,033  Cyclin-dependent kinase 6 inhibitor
0,045  0,010  Dipeptidyl peptidase I inhibitor
0,045  0,011  Ceramide glucosyltransferase inhibitor
0,066  0,032  Potassium channel intermediate-conductance Ca-activated blocker
0,070  0,036  NMDA receptor glycine site agonist
0,061  0,027  Sigma receptor antagonist
0,061  0,028  Pregnane X receptor antagonist
0,086  0,053  GABA A receptor agonist
0,070  0,036  NMDA receptor agonist
0,068  0,035  NMDA 2C receptor antagonist
0,043  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,048  0,015  p53 inhibitor
0,110  0,078  Antineoplastic antimetabolite
0,093  0,061  Antiviral (Rhinovirus)
0,055  0,023  Glucose-6-phosphate isomerase inhibitor
0,053  0,022  Potassium channel small-conductance Ca-activated blocker
0,072  0,040  Gaucher disease treatment
0,153  0,122  Osteoarthritis treatment
0,097  0,066  Chemokine receptor antagonist
0,051  0,020  Glutamate (mGluR1a) antagonist
0,079  0,048  Catalase inhibitor
0,045  0,015  Antiviral (Bovine viral diarrhea virus)
0,053  0,022  Benzodiazepine inverse agonist
0,038  0,008  5 Hydroxytryptamine 1F agonist
0,070  0,039  MDM2 inhibitor
0,166  0,136  Vasodilator
0,042  0,012  Tryptophan 5 hydroxylase inhibitor
0,107  0,078  Proteasome inhibitor
0,059  0,030  Lysine-specific demethylase 1A inhibitor
0,045  0,017  5 Hydroxytryptamine 3B antagonist
0,045  0,016  Vasopressin 1 antagonist
0,046  0,018  Nicotinic receptor beta4 subunit antagonist
0,101  0,073  DOPA decarboxylase inhibitor
0,167  0,139  Acute neurologic disorders treatment
0,061  0,034  Bruton tyrosine kinase inhibitor
0,039  0,012  Protein kinase C beta II inhibitor
0,105  0,077  Calcium channel (voltage-sensitive) blocker
0,092  0,065  Obsessive-compulsive disorder treatment
0,053  0,026  Histamine H4 receptor antagonist
0,115  0,089  NADPH oxidase inhibitor
0,118  0,092  Antifungal enhancer
0,118  0,092  Cytokine production inhibitor
0,084  0,058  5 Hydroxytryptamine 2C antagonist
0,060  0,034  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,114  0,089  Contraceptive
0,094  0,070  Nitric-oxide synthase inhibitor
0,044  0,020  Histone deacetylase 9 inhibitor
0,027  0,002  Immunosuppressant Cyclosporine-like
0,044  0,019  Arginase inhibitor
0,045  0,021  Alpha 1d adrenoreceptor agonist
0,050  0,027  Benzodiazepine antagonist
0,077  0,054  Na+ K+ transporting ATPase inhibitor
0,156  0,133  Antiglaucomic
0,044  0,022  Substance P antagonist
0,087  0,064  GST P1-1 substrate
0,045  0,023  Neurokinin 1 antagonist
0,068  0,046  Phosphodiesterase 4B inhibitor
0,037  0,015  5 Hydroxytryptamine 1D agonist
0,056  0,035  Epithelial sodium channel blocker
0,046  0,025  Histamine H1 receptor agonist
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,043  0,022  Membrane dipeptidase inhibitor
0,046  0,025  Guanylate cyclase inhibitor
0,072  0,051  Cathepsin G inhibitor
0,036  0,015  Protein kinase C beta I inhibitor
0,055  0,034  Melanin-concentrating hormone receptor 1 antagonist
0,110  0,090  Acetylcholinesterase inhibitor
0,056  0,036  Sphingosine kinase 2 inhibitor
0,118  0,098  UGT2B15 substrate
0,049  0,030  5 Hydroxytryptamine 1A agonist
0,045  0,026  GABA B receptor antagonist
0,119  0,101  Peroxidase inhibitor
0,022  0,003  Calcineurin inhibitor
0,162  0,143  Tumour necrosis factor alpha release inhibitor
0,081  0,063  Calcium antagonist
0,037  0,019  Carnitine palmitoyltransferase 1 inhibitor
0,060  0,042  Dopamine D4 antagonist
0,187  0,169  Hypoxia-inducible factor 1 alpha inhibitor
0,050  0,032  Dopamine beta hydroxylase inhibitor
0,034  0,016  Phosphodiesterase 6B inhibitor
0,090  0,072  Interleukin 12 antagonist
0,063  0,046  Calcium channel P-type blocker
0,039  0,022  Kainate receptor 2 antagonist
0,037  0,019  Carnitine palmitoyltransferase inhibitor
0,034  0,017  Vasopressin 1A antagonist
0,057  0,041  Dopamine uptake inhibitor
0,062  0,046  Purinergic P2 antagonist
0,205  0,189  Stroke treatment
0,052  0,035  Aconitate hydratase inhibitor
0,031  0,015  5 Hydroxytryptamine 6 agonist
0,055  0,039  Dihydroorotate oxidase inhibitor
0,059  0,042  Cathepsin E inhibitor
0,061  0,045  Histone deacetylase SIRT3 inhibitor
0,031  0,015  Lysine carboxypeptidase inhibitor
0,083  0,067  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,036  0,020  Vasopressin 2 antagonist
0,076  0,061  Leucine-rich repeat kinase 2 inhibitor
0,035  0,019  Dipeptidyl peptidase II inhibitor
0,040  0,026  AMPA 4 receptor antagonist
0,034  0,020  Protein kinase (CK2) beta inhibitor
0,058  0,043  Cyclin A1 inhibitor
0,055  0,041  Argininosuccinate synthase inhibitor
0,064  0,051  5 Hydroxytryptamine agonist
0,018  0,005  Integrin beta2 antagonist
0,039  0,026  MAP3K5 inhibitor
0,025  0,012  Geranylgeranyltransferase inhibitor
0,029  0,017  Estrogen-related receptor gamma antagonist
0,026  0,013  5 Hydroxytryptamine 4 agonist
0,121  0,108  Genotoxic
0,044  0,032  Purinergic P2Y antagonist
0,027  0,016  Thymidine phosphorylase inhibitor
0,025  0,014  Phosphodiesterase 6H inhibitor
0,025  0,014  Phosphodiesterase 6G inhibitor
0,062  0,050  Dopamine agonist
0,047  0,036  Purinergic P2X antagonist
0,031  0,020  Potassium channel (Inward rectifier) 1 blocker
0,040  0,029  Acid-sensing ion channel blocker
0,044  0,033  Poly(ADP-ribose) polymerase inhibitor
0,019  0,008  Nicotinic alpha4 receptor agonist
0,028  0,018  Motilin receptor antagonist
0,037  0,027  Poly(ADP-ribose) polymerase 1 inhibitor
0,100  0,090  Microtubule formation inhibitor
0,054  0,044  Postcoital contraceptive
0,042  0,032  Histamine H2 receptor agonist
0,063  0,053  Alpha adrenoreceptor agonist
0,042  0,033  Heme oxygenase inhibitor
0,067  0,057  Calcium channel L-type blocker
0,040  0,030  Thymidine kinase inhibitor
0,015  0,006  Cyclin D2 inhibitor
0,029  0,020  Purinergic P2Y15 antagonist
0,033  0,025  Fumarate hydratase inhibitor
0,106  0,097  Cathepsin H inhibitor
0,021  0,012  Antibiotic Quinolone-like
0,190  0,182  Antihypertensive
0,038  0,030  Dopamine D5 agonist
0,035  0,027  Histone deacetylase 7 inhibitor
0,060  0,053  Interferon inducer
0,036  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,026  0,019  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,122  0,115  Hexokinase inhibitor
0,044  0,037  CC chemokine 4 receptor antagonist
0,093  0,086  Antihelmintic (Fasciola)
0,094  0,088  SULT1A1 substrate
0,024  0,018  Calcitonin gene-related peptide antagonist
0,064  0,057  Histidine decarboxylase inhibitor
0,021  0,014  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,047  0,041  5 Hydroxytryptamine 2 agonist
0,171  0,165  Cardioprotectant
0,191  0,185  CYP3A4 inhibitor
0,069  0,063  S-adenosyl-L-methionine decarboxylase inhibitor
0,101  0,096  Aldehyde dehydrogenase inhibitor
0,120  0,114  MAP3K9 inhibitor
0,028  0,023  Peptide deformylase inhibitor
0,107  0,102  Antifungal (Pneumocystis)
0,040  0,034  Histamine H3 receptor antagonist
0,030  0,025  GABA transporter 3 inhibitor
0,015  0,010  CXC chemokine 4 receptor agonist
0,035  0,031  Glutamate (mGluR group II) antagonist
0,044  0,039  Dopamine transporter inhibitor
0,069  0,064  GABA aminotransferase inhibitor
0,013  0,009  Human herpes virus 5 capsid protein P40 inhibitor
0,034  0,030  Glutamate (mGluR3) antagonist
0,046  0,042  Squalene epoxidase inhibitor
0,018  0,014  Vesicular acetylcholine transporter inhibitor
0,040  0,036  Neurokinin 3 antagonist
0,016  0,013  Calcitonin gene-related peptide 1 receptor antagonist
0,029  0,025  Potassium channel small-conductance Ca-activated activator
0,044  0,040  Baculoviral IAP repeat-containing protein inhibitor
0,029  0,025  Epoxide hydrolase 1 inhibitor
0,022  0,019  ICAM 1 antagonist
0,033  0,030  AMPA receptor agonist
0,026  0,023  Myristoyl transferase inhibitor
0,014  0,011  Sodium/hydrogen exchanger 3 inhibitor
0,023  0,021  Sigma 1 receptor antagonist
0,039  0,036  Opioid kappa receptor agonist
0,015  0,013  Carbonic anhydrase X inhibitor
0,015  0,013  Carbonic anhydrase VIII inhibitor
0,137  0,135  I kappa B kinase epsilon inhibitor
0,026  0,024  CDK4/cyclin D3 inhibitor
0,026  0,024  Baculoviral IAP repeat-containing protein 4 inhibitor
0,079  0,077  Granulocyte macrophage colony stimulating factor agonist
0,010  0,008  Angiotensin AT2 receptor agonist
0,106  0,104  Sodium channel blocker
0,006  0,005  Integrin alpha5beta6 antagonist
0,114  0,112  Mannose-6-phosphate isomerase inhibitor
0,024  0,023  Hypoxanthine phosphoribosyltransferase inhibitor
0,080  0,079  HIV-1 integrase (Overall Integration) inhibitor
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,039  0,038  Geranyltranstransferase inhibitor
0,061  0,061  NMDA 2 receptor antagonist
0,061  0,061  Endocannabinoid uptake inhibitor
0,035  0,035  Toll-Like receptor 2 agonist
0,080  0,080  Paget's disease treatment
0,107  0,107  Toll-Like receptor antagonist
0,008  0,008  Folate transporter 1 inhibitor
0,041  0,041  Melanocortin antagonist
0,064  0,063  Antibiotic
0,019  0,019  GABA transporter inhibitor
0,115  0,115  Urinary incontinence treatment

